Prelude Capital Management’s SELLAS Life Sciences SLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-58,338
| Closed | -$72.9K | – | 1412 |
|
|
2024
Q3 | $72.9K | Buy |
58,338
+2,612
| +5% | +$3.27K | ﹤0.01% | 1082 |
|
|
2024
Q2 | $66.3K | Buy |
+55,726
| New | +$66.3K | ﹤0.01% | 1040 |
|
|
2022
Q2 | – | Sell |
-31,125
| Closed | -$208K | – | 1795 |
|
|
2022
Q1 | $208K | Buy |
+31,125
| New | +$208K | 0.01% | 984 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 1746 |
|
|
2017
Q2 | – | Sell |
-5
| Closed | -$5K | – | 1717 |
|
|
2017
Q1 | $5K | Buy |
+5
| New | +$5K | ﹤0.01% | 1343 |
|